We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Could Identify Expectant Mothers at Risk of Preterm Delivery

By LabMedica International staff writers
Posted on 24 Feb 2025

Early preterm birth, defined as delivery before 34 weeks of gestation, carries significant risks for adverse health outcomes. More...

However, there is no universal screening strategy available, which limits the ability to deliver targeted interventions effectively. Researchers have now identified a method to predict which mothers are more likely to experience preterm delivery, opening the door for the development of a universal screening approach.

A research team from Sinai Health (Toronto, ON, Canada) and the University of Toronto (Toronto, ON, Canada) discovered that low levels of placental growth factor (PlGF), a protein crucial for placental development, are linked to preterm birth, specifically before 34 weeks of gestation. The team suggests that a simple blood test to measure PlGF levels in expectant mothers could provide an early indication of the need for enhanced monitoring and delivery planning. PlGF, released into the maternal blood by the placenta, plays a vital role in relaxing maternal blood vessels, helping to stabilize blood pressure despite the increased volume and cardiac output necessary to support the growing baby. It also helps protect the mother from excessive blood loss during delivery. PlGF levels typically rise as the placenta develops, peaking by 28 weeks when the third trimester begins.

Previous research has shown that low PlGF levels are associated with the development of preeclampsia, a dangerous form of hypertension that often requires early delivery. Additionally, fetal growth restriction, which is common in pregnancies with low PlGF levels, accounts for most medically indicated preterm births. The study, which ran from 2020 to 2023, involved over 9,000 pregnant women who had their PlGF levels tested through a blood sample taken during the routine gestational diabetes screening between 24 and 28 weeks. The researchers reviewed the medical records of these patients, assessing birth outcomes such as weight and gestational age at birth. They also checked for preeclampsia by reviewing bloodwork and blood pressure data, confirming the link between low PlGF levels and key pregnancy complications.

The study found that when PlGF levels fell below 100 picograms per milliliter between 24 and 28 weeks of gestation, the risk of preterm birth before 34 weeks was nearly 50 times higher. As only about 1.5% of the population falls into this category, the PlGF test is highly specific, with a low risk of false positives. The prospective observational study, published in JAMA Network Open, demonstrated that factors such as weight, race, and previous pregnancy outcomes did not influence the association between low PlGF levels and preterm birth. This makes PlGF screening a unimodal test, in contrast to most pregnancy screenings, which rely on multiple data points for algorithmic analysis. Many hospitals already have the necessary laboratory technology and expertise to conduct this test, as PlGF is part of early pregnancy risk assessments for Down’s syndrome (trisomy 21). The next step for the research team is to conduct a randomized controlled trial that evaluates the maternal and fetal health benefits of PlGF screening, along with its associated costs, in an effort to encourage provincial and territorial governments to adopt this test.

“This means it’s a very simple test to interpret,” said John Kingdom, a clinician-scientist at the Lunenfeld-Tanenbaum Research Institute at Sinai Health and U of T professor of obstetrics and gynecology. “It doesn’t matter how tall you are, whether you’re Black or white, or if you’ve had a baby before – the test interpretation remains valid regardless of those inputs.”


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.